Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Benjamin Andrick"'
Publikováno v:
INNOVATIONS in Pharmacy, Vol 15, Iss 2 (2024)
Description of the Problem: Rates of pharmacy residency research projects making it to peer review and publication are low (between two and seven percent). Little is known about the influence of preceptor development on moving projects to peer-review
Externí odkaz:
https://doaj.org/article/c5d5f66275b94d58aebb8fce78916f7c
Autor:
Joseph Vadakara, Benjamin Andrick
Publikováno v:
Chronic Diseases and Translational Medicine, Vol 5, Iss 1, Pp 15-24 (2019)
Hodgkin’s lymphoma is a highly treatable malignancy. It has high cure rates yet there are many patients who relapse or are refractory to treatment. Traditionally, treatment has been with conventional chemotherapy; however, the development of brentu
Externí odkaz:
https://doaj.org/article/581c062dee694a08ac01bdf0eca28236
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 6:24-28
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:e1033-e1049
AML is a biologically and clinically heterogeneous disease that is associated with poor overall long-term survival. The expanding knowledge of genomic landscape in AML as well as advancements in molecular and chemical biology over the pathway in AML.
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 28(4)
Background Generally national guidelines for febrile neutropenia recommend treatment with cefepime 2 g every 8 h. Due to beta-lactam’s time dependent killing effects, it is hypothesized smaller doses given more frequently might be non-inferior. The
Autor:
Benjamin Andrick, Dennis Marjoncu
Publikováno v:
Journal of the Advanced Practitioner in Oncology
Acute myeloid leukemia (AML) is the most common adult leukemia, with an overall poor prognosis. New agents targeting various receptors may improve treatment outcomes and overall survival. FMS-like tyrosine kinase 3 (FLT3) is a targetable mutation occ
Publikováno v:
The Annals of pharmacotherapy. 55(9)
Background Venous thromboembolism (VTE) is a complication of cancer, for which low-molecular-weight heparin (LMWH) remains the preferred anticoagulant. Enoxaparin is traditionally dosed using weight. In certain populations, monitoring anti-Xa levels
Autor:
Benjamin Andrick, Lorraine Tusing, Laney K. Jones, Yirui Hu, Rachel Sneidman, Christina Gregor, Soumit Basu, Joseph P. Lynch, Joseph Vadakara
Publikováno v:
Transplantation and Cellular Therapy. 28:334.e1-334.e9
The hematopoietic cellular therapy (HCT) pharmacist is an essential member of the multidisciplinary care team. Yet, standardized incorporation of a pharmacist at transplantation centers remains challenging. Implementation science uses theory-driven a
Autor:
Durga Zally, Erika Leese, Benjamin Andrick, Na Tosha Gatson, Anupama Divakaruni Mathur, Grant W Lee
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 26(8)
Purpose To evaluate neuro-oncology clinician time utilization for medication management and identify a cost beneficial role for integration of a dedicated pharmacy specialists. Methods A pharmacist was temporarily integrated into a neuro-oncology cli
Publikováno v:
Transplantation and Cellular Therapy. 28:S466